Kevin Ariën

Medicine & Life Sciences

1. Alphavirus 35%
2. Anti-HIV Agents 13%
3. Anti-Infective Agents 90%
4. Antibodies 32%
5. Antibody Formation 15%
6. Antigens 19%
7. Antiviral Agents 17%
8. Arboviruses 21%
9. Aruba 25%
10. Belgium 49%
11. Chikungunya Fever 21%
12. Chikungunya virus 69%
13. Cohort Studies 14%
14. Coronavirus 40%
15. Culicidae 21%
16. Dapivirine 39%
17. Democratic Republic of the Congo 44%
18. Dengue 20%
19. Dengue Virus 18%
20. Disease Outbreaks 47%
21. Ebola Hemorrhagic Fever 14%
22. Ebolavirus 20%
23. Female Genitalia 16%
24. Foams and Jellies Vaginal Creams 13%
25. Gels 18%
26. Genitalia 20%
27. Genotype 18%
28. Health Personnel 17%
29. HIV 66%
30. HIV-1 79%
31. Humoral Immunity 16%
32. Immunoglobulin G 19%
33. In Vitro Techniques 25%
34. Infection 32%
35. Messenger RNA 25%
36. Mutation 16%
37. Neutralization Tests 23%
38. Neutralizing Antibodies 38%
39. Reverse Transcriptase Inhibitors 62%
40. RNA 15%
41. Routine Diagnostic Tests 24%
42. SARS Virus 100%
43. Serologic Tests 14%
44. Severe Acute Respiratory Syndrome 27%
45. T-Lymphocytes 17%
46. Triazines 18%
47. Vaccination 37%
48. Vaccines 28%
49. Viruses 58%
50. Zika Virus 44%